Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07805473) titled '[18F]F-DED PET Imaging of Reactive Astrocytes in Multiple Sclerosis' on Sept. 1.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
Primary Sponsor: Parc de Salut Mar
Condition:
Multiple Sclerosis
Intervention:
Drug: [18F]fluorodeprenyl-D2
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: December 1, 2026
Target Sample Size: 30
Countries of Recruitment:
Spain
To know more, visit https://clinicaltrials.gov/study/NCT07805473
Published by HT Digital Content Services with pe...